As of 2025-03-16, the EV/EBITDA ratio of Profound Medical Corp (PRN.TO) is -7.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRN.TO's latest enterprise value is 223.75 mil CAD. PRN.TO's TTM EBITDA according to its financial statements is -31.48 mil CAD. Dividing these 2 quantities gives us the above PRN.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 17.2x | 14.2x |
| Forward P/E multiples | 10.0x - 15.4x | 12.2x |
| Fair Price | (16.12) - (22.32) | (19.04) |
| Upside | -261.2% - -323.2% | -290.4% |
| Date | EV/EBITDA |
| 2025-03-14 | -7.80 |
| 2025-03-13 | -7.96 |
| 2025-03-12 | -8.17 |
| 2025-03-11 | -7.52 |
| 2025-03-10 | -7.66 |
| 2025-03-07 | -7.87 |
| 2025-03-06 | -8.28 |
| 2025-03-05 | -8.25 |
| 2025-03-04 | -8.25 |
| 2025-03-03 | -8.07 |
| 2025-02-28 | -7.86 |
| 2025-02-27 | -8.22 |
| 2025-02-26 | -8.35 |
| 2025-02-25 | -8.11 |
| 2025-02-24 | -8.54 |
| 2025-02-21 | -8.53 |
| 2025-02-20 | -8.45 |
| 2025-02-19 | -8.05 |
| 2025-02-18 | -7.60 |
| 2025-02-14 | -7.54 |
| 2025-02-13 | -7.02 |
| 2025-02-12 | -6.93 |
| 2025-02-11 | -6.76 |
| 2025-02-10 | -6.41 |
| 2025-02-07 | -6.58 |
| 2025-02-06 | -6.86 |
| 2025-02-05 | -6.92 |
| 2025-02-04 | -6.95 |
| 2025-02-03 | -6.85 |
| 2025-01-31 | -7.27 |
| 2025-01-30 | -7.31 |
| 2025-01-29 | -7.00 |
| 2025-01-28 | -7.46 |
| 2025-01-27 | -7.93 |
| 2025-01-24 | -8.12 |
| 2025-01-23 | -8.37 |
| 2025-01-22 | -8.29 |
| 2025-01-21 | -8.33 |
| 2025-01-20 | -8.20 |
| 2025-01-17 | -8.49 |
| 2025-01-16 | -8.63 |
| 2025-01-15 | -8.50 |
| 2025-01-14 | -8.36 |
| 2025-01-13 | -8.62 |
| 2025-01-10 | -8.81 |
| 2025-01-09 | -9.06 |
| 2025-01-08 | -9.00 |
| 2025-01-07 | -8.91 |
| 2025-01-06 | -8.89 |
| 2025-01-03 | -9.12 |